Tesaro Inc (TSRO) financial statements (2021 and earlier)
Company profile
Business Address |
1000 WINTER STREET, SUITE 3300 WALTHAM, MA 02451 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 477 | 575 | 499 | 643 | 521 | 508 | 672 | ||
Cash and cash equivalents | 477 | 575 | 499 | 643 | 521 | 508 | 672 | ||
Receivables | 31 | 36 | 44 | 53 | 28 | 23 | 6 | ||
Inventory, net of allowances, customer advances and progress billings | 109 | 87 | 74 | 58 | 51 | 28 | 16 | ||
Inventory | 109 | 87 | 74 | 58 | 51 | 28 | 16 | ||
Assets held-for-sale, not part of disposal group | 22 | ||||||||
Other current assets | 31 | 37 | 38 | 34 | 22 | 23 | 14 | ||
Total current assets: | 648 | 757 | 656 | 788 | 622 | 582 | 708 | ||
Noncurrent Assets | |||||||||
Property, plant and equipment | 10 | 11 | 10 | 10 | 10 | 10 | 9 | ||
Intangible assets, net (including goodwill) | 36 | 37 | 55 | 56 | 43 | 44 | 37 | ||
Intangible assets, net (excluding goodwill) | 36 | 37 | 55 | 56 | 43 | 44 | 37 | ||
Restricted cash and investments | 9 | 3 | 3 | 3 | 3 | 3 | 2 | ||
Other noncurrent assets | 8 | 3 | 6 | 6 | 8 | 6 | 5 | ||
Total noncurrent assets: | 62 | 53 | 74 | 74 | 64 | 63 | 53 | ||
TOTAL ASSETS: | 711 | 810 | 730 | 862 | 686 | 645 | 761 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 179 | 172 | 156 | 159 | 129 | 100 | 79 | ||
Accounts payable | 28 | 13 | 5 | 4 | 6 | 0 | 10 | ||
Accrued liabilities | 151 | 159 | 151 | 155 | 123 | 100 | 69 | ||
Deferred revenue and credits | ✕ | ✕ | ✕ | 0 | 0 | 0 | |||
Contract with customer, liability | 1 | 0 | ✕ | ✕ | ✕ | ✕ | |||
Other liabilities | 11 | 11 | 7 | 7 | 2 | 3 | 3 | ||
Other undisclosed current liabilities | 0 | 0 | 25 | ||||||
Total current liabilities: | 190 | 184 | 163 | 166 | 131 | 102 | 107 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 644 | 640 | 440 | 437 | |||||
Long-term debt, excluding current maturities | 644 | 640 | 440 | 437 | |||||
Liabilities, other than long-term debt | 8 | 8 | 8 | 10 | 7 | 6 | 6 | ||
Deferred revenue and credits | ✕ | ✕ | ✕ | 0 | 0 | 0 | |||
Contract with customer, liability | 0 | 0 | ✕ | ✕ | ✕ | ✕ | |||
Other liabilities | 7 | 8 | 8 | 10 | 6 | 5 | 6 | ||
Other undisclosed noncurrent liabilities | 0 | 0 | 140 | 137 | 135 | ||||
Total noncurrent liabilities: | 651 | 648 | 449 | 447 | 147 | 143 | 140 | ||
Total liabilities: | 842 | 832 | 612 | 613 | 278 | 245 | 248 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | (131) | (22) | 118 | 249 | 407 | 400 | 513 | ||
Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Additional paid in capital | 1,814 | 1,786 | 1,756 | 1,725 | 1,698 | 1,665 | 1,627 | ||
Accumulated other comprehensive loss | (8) | (8) | (5) | (6) | (2) | (3) | (3) | ||
Accumulated deficit | (1,936) | (1,799) | (1,633) | (1,470) | (1,288) | (1,263) | (1,110) | ||
Total stockholders' equity: | (131) | (22) | 118 | 249 | 407 | 400 | 513 | ||
TOTAL LIABILITIES AND EQUITY: | 711 | 810 | 730 | 862 | 686 | 645 | 761 |
Income statement (P&L) ($ in millions)
9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 64 | 57 | 50 | 48 | 143 | 29 | 3 | |
Revenue, net | ✕ | ✕ | ✕ | 143 | 29 | 3 | ||
Cost of revenue (Cost of Goods and Services Sold) | (14) | (14) | (10) | (31) | (6) | (4) | (0) | |
Gross profit: | 50 | 44 | 40 | 17 | 137 | 26 | 3 | |
Operating expenses | (203) | (213) | (202) | (224) | (165) | (178) | (136) | |
Other undisclosed operating income | 14 | 14 | 10 | 31 | 6 | 4 | 0 | |
Operating loss: | (138) | (155) | (152) | (176) | (22) | (149) | (133) | |
Nonoperating income | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |
Investment income, nonoperating | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |
Other nonoperating income | 0 | 0 | 0 | 0 | 0 | |||
Interest and debt expense | (18) | (13) | (12) | (7) | (4) | (4) | (4) | |
Loss from continuing operations before equity method investments, income taxes: | (154) | (167) | (162) | (181) | (25) | (152) | (137) | |
Other undisclosed income from continuing operations before income taxes | 18 | |||||||
Loss from continuing operations before income taxes: | (137) | (167) | (162) | (181) | (25) | (152) | (137) | |
Income tax expense (benefit) | (0) | 0 | (0) | (1) | (0) | (0) | (0) | |
Net loss available to common stockholders, diluted: | (137) | (167) | (163) | (182) | (25) | (152) | (137) |
Comprehensive Income ($ in millions)
9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (137) | (167) | (163) | (182) | (25) | (152) | (137) | |
Other comprehensive income | 0 | 0 | 0 | 3 | 0 | 0 | 0 | |
Comprehensive loss: | (137) | (167) | (163) | (179) | (25) | (152) | (137) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (0) | (3) | 0 | (7) | 0 | 0 | 0 | |
Comprehensive loss, net of tax, attributable to parent: | (137) | (169) | (162) | (186) | (25) | (152) | (137) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.